Your browser doesn't support javascript.
loading
Identification of macrocyclic peptides which activate bacterial cylindrical proteases.
Walther, Raoul; Westermann, Linda M; Carmali, Sheiliza; Jackson, Sophie E; Brötz-Oesterhelt, Heike; Spring, David R.
Afiliación
  • Walther R; Yusuf Hamied Department of Chemistry, University of Cambridge Lensfield Road CB2 1EW Cambridge UK spring@ch.cam.ac.uk.
  • Westermann LM; Interfaculty Institute of Microbiology and Infection Medicine, Dept. of Bioactive Compounds, University of Tübingen Auf der Morgenstelle 28 72076 Tübingen Germany heike.broetz-oesterhelt@uni-tuebingen.de.
  • Carmali S; School of Pharmacy, Queen's University Belfast BT9 7BL Belfast UK.
  • Jackson SE; Yusuf Hamied Department of Chemistry, University of Cambridge Lensfield Road CB2 1EW Cambridge UK spring@ch.cam.ac.uk.
  • Brötz-Oesterhelt H; Interfaculty Institute of Microbiology and Infection Medicine, Dept. of Bioactive Compounds, University of Tübingen Auf der Morgenstelle 28 72076 Tübingen Germany heike.broetz-oesterhelt@uni-tuebingen.de.
  • Spring DR; Cluster of Excellence Controlling Microbes to Fight Infections Germany.
RSC Med Chem ; 14(6): 1186-1191, 2023 Jun 22.
Article en En | MEDLINE | ID: mdl-37360394
ABSTRACT
The caseinolytic protease complex ClpXP is an important house-keeping enzyme in prokaryotes charged with the removal and degradation of misfolded and aggregated proteins and performing regulatory proteolysis. Dysregulation of its function, particularly by inhibition or allosteric activation of the proteolytic core ClpP, has proven to be a promising strategy to reduce virulence and eradicate persistent bacterial infections. Here, we report a rational drug-design approach to identify macrocyclic peptides which increase proteolysis by ClpP. This work expands the understanding of ClpP dynamics and sheds light on the conformational control exerted by its binding partner, the chaperone ClpX, by means of a chemical approach. The identified macrocyclic peptide ligands may, in the future, serve as a starting point for the development of ClpP activators for antibacterial applications.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: RSC Med Chem Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: RSC Med Chem Año: 2023 Tipo del documento: Article